Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van der Flier

Showing results (151-160 of 791) with videos related to

Pageof 80
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE projectMarleen Kunneman, Ellen M A Smets, Femke H Bouwman, et al.
Clinical Chemistry|October 17, 2009
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder, Nicolaas A Verwey, Wiesje M van der Flier, et al.
Stroke|July 16, 2015
White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive DeclineMarije R Benedictus, Argonde C van Harten, Annebet E Leeuwis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2023
The potential clinical value of plasma biomarkers in Alzheimer's diseaseKaj Blennow, Douglas Galasko, Robert Perneczky, et al.
Annals of Neurology|March 21, 2017
Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjectsBetty M Tijms, Daniela Bertens, Rosalinde E Slot, et al.
Alzheimer'S Research & Therapy|July 30, 2018
Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic reviewArno de Wilde, Marieke M van Buchem, René H J Otten, et al.
Tijdschrift Voor Gerontologie En Geriatrie|April 6, 2023
[A survey study towards the opinions of clinicians, patients and care partners regarding computer tools in the memory clinic: sense or nonsense?]Aniek M van Gils, Leonie Nc Visser, Heleen Ma Hendriksen, et al.
Dementia and Geriatric Cognitive Disorders|July 8, 2010
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic populationF H Bouwman, N A Verwey, M Klein, et al.
Neurobiology of Aging|October 18, 2017
Gray matter networks and clinical progression in subjects with predementia Alzheimer's diseaseBetty M Tijms, Mara Ten Kate, Alida A Gouw, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2015
Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's DiseaseEls Coart, Leandro García Barrado, Flora H Duits, et al.
Pageof 80

Showing results (151-160 of 791) with videos related to

Sort By:
Pageof 80
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE projectMarleen Kunneman, Ellen M A Smets, Femke H Bouwman, et al.
Clinical Chemistry|October 17, 2009
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder, Nicolaas A Verwey, Wiesje M van der Flier, et al.
Stroke|July 16, 2015
White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive DeclineMarije R Benedictus, Argonde C van Harten, Annebet E Leeuwis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2023
The potential clinical value of plasma biomarkers in Alzheimer's diseaseKaj Blennow, Douglas Galasko, Robert Perneczky, et al.
Annals of Neurology|March 21, 2017
Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjectsBetty M Tijms, Daniela Bertens, Rosalinde E Slot, et al.
Alzheimer'S Research & Therapy|July 30, 2018
Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic reviewArno de Wilde, Marieke M van Buchem, René H J Otten, et al.
Tijdschrift Voor Gerontologie En Geriatrie|April 6, 2023
[A survey study towards the opinions of clinicians, patients and care partners regarding computer tools in the memory clinic: sense or nonsense?]Aniek M van Gils, Leonie Nc Visser, Heleen Ma Hendriksen, et al.
Dementia and Geriatric Cognitive Disorders|July 8, 2010
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic populationF H Bouwman, N A Verwey, M Klein, et al.
Neurobiology of Aging|October 18, 2017
Gray matter networks and clinical progression in subjects with predementia Alzheimer's diseaseBetty M Tijms, Mara Ten Kate, Alida A Gouw, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2015
Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's DiseaseEls Coart, Leandro García Barrado, Flora H Duits, et al.
Pageof 80